RECOMMENDED PRODUCTS
| CATALOG NO | PRODUCT NAME | CAS | PURITY | STRUCTURE |
|---|---|---|---|---|
| 18381 | JPH203 HCl ( Nanvuranlat ) | 1597402-27-1 | ≧98.0% |  |
| JPH203, also known as KYT-0353, is a potent and selective LAT1 selective ( L-type ami | ||||
| 1811211 | Anlotinib HCl ( AL-3818 ) | 1360460-82-7 | ≧98.0% |  |
| Anlotinib is a novel oral tyrosine kinase inhibitor (TKI) targeting c-kit, platelet-d | ||||
| 21257 | Difelikefalin | 1024828-77-0 | ≧98.0% |  |
| Difelikefalin HCl is in stock.Difelikefalin, also known CR-845; MR-13A-9; MR-13A9, is | ||||
| 20259 | Elinzanetant ( NT-814 ) | 929046-33-3 | ≧98.0% |  |
| Elinzanetant, previously known as NT-814 (45), is a dual NK1,3R antagonist and theref | ||||
| 18435 | Ritlecitinib ( PF-06651600 ) | 1792180-81-4 | ≧98.0% | _1792180-81-4.png) |
| Ritlecitinib ( PF-06651600 ) is a potent and selective JAK3 inhibitor. PF-06651600, a | ||||
| 20273 | Delgocitinib（JTE-052） | 1263774-59-9 | ≧98.0% |  |
| Delgocitinib, also known as LEO-124249 and JTE052, is a potent and selective JAK inhi | ||||
| 61726 | Ensifentrine ( RPL554 ) | 1884461-72-6 | ≧98.0% | _1884461-72-6.png) |
| Ensifentrine (RPL554) is an investigational, first-in-class, inhaled dual inhibitor o | ||||
| 20281 | ABT-384 | 868623-40-9 | ≧98.0% |  |
| ABT-384 is a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase type | ||||
| 21224 | BI-187004 | 1303515-32-3 | ≧98.0% |  |
| BI-187004, also known as VTP-34072, is an 11β-hydroxysteroid dehydrogenase 1 inhibit | ||||
| 20258 | CRT0273750 | 1979939-16-6 | ≧98.0% |  |
| CRT0273750 modulates LPA levels in plasma and is suitable for in vivo studies. | ||||
| 20102901 | Razuprotafib | 1008510-37-9 | ≧98.0% |  |
| Razuprotafib, also known as AKB-9778, is a small molecule inhibitor of vascular endot | ||||
| 2105071 | AP1189 acetate | 959850-74-9 | ≧98.0% |  |
| AP1189 is a melanocortin receptor agonist on MC1 and MC3 receptors. | ||||